Wheaton Franciscan Medical GroupWheaton Franciscan Family Medicine Specialty Services 3070 N 51 St FL 6, Milwaukee, WI 53210 (414)4456520 (phone), (414)4456875 (fax)
Wheaton Franciscan Medical Group 4655 N Prt Washington Rd STE 100, Milwaukee, WI 53212 (414)9617444 (phone), (414)5275732 (fax)
Education:
Medical School Des Moines University College of Osteopathic Medicine Graduated: 1979
Procedures:
Amniocentesis Hysterectomy Cesarean Section (C-Section) D & C Dilation and Curettage Delivery After Previous Caesarean Section Ovarian Surgery Tubal Surgery Vaccine Administration Vaginal Delivery
Conditions:
Genital HPV Uterine Leiomyoma Abnormal Vaginal Bleeding Breast Disorders Candidiasis of Vulva and Vagina
Languages:
English Spanish
Description:
Dr. Gilman graduated from the Des Moines University College of Osteopathic Medicine in 1979. He works in Milwaukee, WI and 1 other location and specializes in Obstetrics & Gynecology. Dr. Gilman is affiliated with Columbia St Marys Hospital Milwaukee and Wheaton Franciscan Healthcare Saint Joseph Hospital.
Bramblebush Primary Care 21 Bramble Bush Dr, Falmouth, MA 02540 (508)4955160 (phone), (508)4955170 (fax)
Education:
Medical School Kath Univ Leuven, Fac Der Geneeskunde, Leuven, Belgium Graduated: 1980
Languages:
English
Description:
Mr. Gilman graduated from the Kath Univ Leuven, Fac Der Geneeskunde, Leuven, Belgium in 1980. He works in Falmouth, MA and specializes in Internal Medicine. Mr. Gilman is affiliated with Cape Cod Hospital and Falmouth Hospital.
Sep 2014 to 2000 Systems AnalystNovacoast Pittsburg, KS Feb 2012 to Nov 2013 IT Consultant/EngineerEastern Shawnee Tribe of Oklahoma Wyandotte, OK Dec 2007 to Jul 2011 System AdministratorBordertown Casino Wyandotte, OK Apr 2007 to Dec 2007 System AdministratorLTI Publications Grove, OK Jul 2004 to Apr 2007 Programmer
Saint Joseph of Cluny Sisters School Newport RI 2000-2004
Community:
Stephen Ferris, Doug Prindle, Ashley Sawyer, Susan Sullivan, Cathy Jameson, Matt Kerr, Frank Abagnale, Patrick Davis, Edward Carlz, Jason Roach, Leslie Oman
By targeting PADs, it may be possible to eliminate the antigens that drive autoimmunity with limited impact on the immune system, thereby creating breakthrough treatments, said Michael Gilman, PhD, founder and chief executive officer, Padlock Therapeutics. In Bristol-Myers Squibb, we found an exc
Date: Mar 23, 2016
Category: Business
Source: Google
Pfizer, Novartis chip in on $17M round for an Atlas upstart focused on pain
in its facilities. Bruce Booth is stepping in as chairman of this one, as well as others, and Pojasek will be working closely with a team of experienced hands at Atlas that also includes Michael Gilman, who founded Stromedix and later helped orchestrate a sale of the company to Biogen Idec ($BIIB).
Date: Oct 23, 2014
Category: Health
Source: Google
Raze Therapeutics Launches with $24 Million Series A Financing to Advance a ...
Razes Scientific Advisory Board includes our three scientific founders, Keith Flaherty, MD and Michael Gilman, PhD. Dr. Flaherty is the director of the Henri and Belinda Termeer Center for Targeted Therapies at the Massachusetts General Cancer Center and Associate Professor of
Date: Oct 14, 2014
Category: Health
Source: Google
Novartis joins an Atlas syndicate to back cancer drug upstart Raze
Atlas brought the three together to provide the scientific foundation for Raze, and Rhodes also notes that the experienced biotech vet Michael Gilman, who had run Stromedix before Biogen Idec ($BIIB) bought out the company and brought him back into the company for a short stint, played an instrument
A little of the mystery disappears when one considers the old adage, You can never stick the same foot in the same river twice. When Biogen Idec let go of STX-100, adifferent team was in place. Stromedix CEO Michael Gilman, who is now returning to Biogen Idec, had resigned NextPage
Date: Feb 14, 2012
Category: Business
Source: Google
Biogen Idec scores lung disease drug in $562.5M buyout of Stromedix
nd a need for midstage assets, Biogen'sStromedix acquisition gives it the startup's lead program in idiopathic pulmonary fibrosis (IPF). Stromedix CEO Michael Gilman, a former EVP of R&D at Biogen, said his company is now recruiting patients for the midstage IPF trial for the antibody STX-100. I
Date: Feb 14, 2012
Category: Business
Source: Google
Small business' hope for the State of the Union: A remedy for uncertainty
Michael Gilman, owner of hair product retailer Grooming Lounge, brought up another common concern small business owners hope to have addressed on Tuesday access to capital. His Washington-based company plans to launch new products and open new locations in the coming months, but those plans hinge